Editorial: Pharmacokinetic-pharmacodynamic model of drugs and their pharmacokinetic differences between normal and disease states

被引：0
|
作者：
Gong, Zipeng [1 ,2 ,3 ]
Chen, Ruixing [1 ]
Ye, Ling [4 ]
Ma, Guo [5 ]
Xian, Yanfang [6 ]
Kulkarni, Kaustubh [7 ]
机构：
[1] Guizhou Med Univ, Sch Pharm, State Key Lab Funct & Applicat Med Plants, Guizhou Prov Key Lab Pharmaceut, Guiyang, Peoples R China
[2] Zunyi Med Univ, Key Lab Basic Pharmacol, Minist Educ, Zunyi, Peoples R China
[3] Guizhou Med Univ, Guizhou Prov Engn Res Ctr Dev & Applicat Ethn Med, Guiyang, Peoples R China
[4] Southern Med Univ, Sch Pharmaceut Sci, NMPA Key Lab Res & Evaluat Drug Metab, Guangdong Prov Key Lab New Drug Screening, Guangzhou 510515, Peoples R China
[5] Fudan Univ, Sch Pharm, Shanghai, Peoples R China
[6] Chinese Univ Hong Kong, Fac Med, Sch Chinese Med, Shatin, Hong Kong, Peoples R China
[7] Boundless Bio Inc, San Diego, CA USA
来源：
FRONTIERS IN PHARMACOLOGY | 2024年 / 15卷
基金：
中国国家自然科学基金;
关键词：
normal status; disease states; metabolizing enzymes; transporters; pharmacokinetic-pharmacodynamic link model;
D O I：
10.3389/fphar.2024.1451176
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Pharmacokinetic-pharmacodynamic relationships for analgesics
    Suri, A
    Estes, KS
    Geisslinger, G
    Derendorf, H
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1997, 35 (08) : 307 - 323
  • [22] A pharmacokinetic-pharmacodynamic disease model to predict in vivo antiviral activity of maraviroc
    Rosario, MC
    Jacqmin, P
    Dorr, P
    van der Ryst, E
    Hitchcock, C
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (05) : 508 - 519
  • [23] Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic models
    Siripuram, Vijay K.
    Wright, Daniel F. B.
    Barclay, Murray L.
    Duffull, Stephen B.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 (05) : 415 - 423
  • [24] Pharmacokinetic-pharmacodynamic modeling of opioids
    Lötsch, JR
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2005, 29 (05) : S90 - S103
  • [25] Pharmacokinetic-pharmacodynamic relationships for benzodiazepines
    Laurijssens, BE
    Greenblatt, DJ
    CLINICAL PHARMACOKINETICS, 1996, 30 (01) : 52 - 76
  • [26] Pharmacokinetic-pharmacodynamic correlations in psychopharmacology
    Danhof, M.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S112 - S113
  • [27] Microdialysis for pharmacokinetic-pharmacodynamic studies
    Yu, W.
    Cheng, Q.
    Feng, J.
    Li, F.
    PHARMAZIE, 2007, 62 (12): : 883 - 891
  • [28] PHARMACOKINETIC-PHARMACODYNAMIC MODELING IN PAIN
    Loetsch, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 14 - 14
  • [29] Pharmacokinetic-pharmacodynamic modelling in anaesthesia
    Gambus, Pedro L.
    Troconiz, Inaki F.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 79 (01) : 72 - 84
  • [30] PHARMACOKINETIC-PHARMACODYNAMIC COMPARISON OF GANAXOLONE IN NORMAL RATS AND IN A RAT MODEL OF CATAMENIAL EPILEPSY
    Reddy, Doodipala S.
    Rogawski, M. A.
    EPILEPSIA, 2008, 49 : 371 - 371
12345